BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17201818)

  • 1. Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome.
    Orio F; Palomba S; Giallauria F; Colao A; Vigorito C
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):152-3. PubMed ID: 17201818
    [No Abstract]   [Full Text] [Related]  

  • 2. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F; Palomba S; Maresca L; Vuolo L; Tafuri D; Lombardi G; Colao A; Vigorito C; Francesco O
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk in women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S20-1. PubMed ID: 16798279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW; Nestler JE
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance as link between polycystic ovary syndrome and cardiovascular autonomic dysfunction.
    Perciaccante A
    Int J Cardiol; 2009 Jul; 135(3):e78-9. PubMed ID: 18639353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk in women with polycystic ovarian syndrome.
    Guzick DS
    Semin Reprod Endocrinol; 1996 Feb; 14(1):45-9. PubMed ID: 8796926
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term consequences of polycystic ovary syndrome on cardiovascular risk.
    Rizzo M; Berneis K; Spinas G; Rini GB; Carmina E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1563-7. PubMed ID: 18976752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.
    Meyer C; McGrath BP; Teede HJ
    Diabetes Care; 2007 Mar; 30(3):471-8. PubMed ID: 17327307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase levels in women with polycystic ovary syndrome.
    Fenkci IV; Serteser M; Fenkci S; Kose S
    J Reprod Med; 2007 Oct; 52(10):879-83. PubMed ID: 17977159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW; Atkin SL
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.
    Diamanti-Kandarakis E; Economou FN; Livadas S; Tantalaki E; Piperi C; Papavassiliou AG; Panidis D
    Kidney Blood Press Res; 2009; 32(1):24-31. PubMed ID: 19212122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal fat distribution and insulin resistance in Indian women with polycystic ovarian syndrome.
    Kalra P; Bansal B; Nag P; Singh JK; Gupta RK; Kumar S; Rathore RK; Bhatia V; Bhatia E
    Fertil Steril; 2009 Apr; 91(4 Suppl):1437-40. PubMed ID: 18722605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.